logo
  

HCA Healthcare Boosts FY23 Outlook; Declares Dividend - Update

While reporting financial results for the second quarter on Thursday, healthcare provider HCA Healthcare, Inc. (HCA) raised its earnings and revenue guidance for the full-year 2023.

For fiscal 2023, the company now projects earnings in a range of $17.70 to $18.90 per share on revenues between $63.25 billion and $64.75 billion.

Previously, the company expected earnings in the range of $17.25 to $18.55 per share on revenues between $62.5 billion and $64.5 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $18.17 per share on revenues of $63.50 billion for the year. Analysts' estimates typically exclude special items.

The company's Board of Directors also declared a quarterly cash dividend of $0.60 per share on the Company's common stock, payable on September 29, 2023 to stockholders of record at the close of business on September 15, 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
RELATED NEWS
Follow RTT